An invalid vocabulary is selected. Please change it in the options.
Title Creditssort descending Start date - Expiration date
Evaluating Immune Checkpoint Inhibition Response Biomarkers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #1: Applying Biomarkers in Risk Stratification of Localized Prostate Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #2: Applying Biomarkers in Breast Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Clinical Scenario #3: Applying Biomarkers in Central Nervous System Cancers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Clinical Scenario #4: Applying Biomarkers in Non-Small Cell Lung Cancer 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Chronic Myeloid Leukemia/Myelofibrosis: TKI Therapy and Toxicity Management 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Clinical Scenario #5: Applying Biomarkers in Biliary Tract Cancers 0.75 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Prophylactic Vaccines/Immunizations for Cancer Patients 0.75 08/04/2022 - 12:00am to 08/04/2024 - 12:00am
Psychotherapeutic Strategies and Pharmacotherapy Options for Addressing Distress in Cancer Patients 0.75 08/04/2022 - 12:00am to 08/04/2024 - 12:00am
Case Studies in the Management of Leukemia 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
NCCN Guidelines® Insights - Survivorship, Version 1.2023 1.00 08/10/2023 - 12:00am to 08/10/2024 - 12:00am
What is Biomarker Testing, and Why Is It Important? 1.00 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Treatment of Deficient Mismatch Repair or Microsatellite Instability-High (dMMR/MSI-H) Colorectal Cancer 1.00 08/18/2023 - 12:00am to 08/18/2024 - 12:00am
Immunotherapy in Hepatocellular Carcinoma: Improving the Treatment Paradigm Within Community Practice 1.00 12/19/2023 - 12:00am to 12/19/2024 - 12:00am

Pages